Kalderos
Traverse Fund III
We launched Kalderos to become the world's first Drug Discount Management platform: a unifying, multi-stakeholder technology that brings trust and efficiency to drug discount and rebate programs, empowering healthcare stakeholders to better serve patients.
Kalderos is the world’s first drug discount management platform. They are on a mission to solve the systemic problems of the U.S. healthcare system by building unifying technologies that bring transparency, trust, and equity to the entire healthcare community. By working with healthcare providers, drug manufacturers, payers, and government agencies, Kalderos is lowering the cost of healthcare and enabling everyone to focus on improving the health of patients.
Team:
2019
Year Invested
Active
Status
A
Series/Stage
$7M
Round Size